Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

De novopurine biosynthesis is a major driver of chemoresistance in glioblastoma
Jack Shireman, Fatemeh Atashi, Gina Lee, et al.
Brain (2021) Vol. 144, Iss. 4, pp. 1230-1246
Open Access | Times Cited: 54

Showing 26-50 of 54 citing articles:

Reversal of cancer gene expression identifies repurposed drugs for diffuse intrinsic pontine glioma
Guisheng Zhao, Patrick Newbury, Yukitomo Ishi, et al.
Acta Neuropathologica Communications (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 12
Lower ratio of IMPDH1 to IMPDH2 sensitizes gliomas to chemotherapy
X Ruan, Yundong Xiong, Xiaoman Li, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 7, pp. 1081-1089
Closed Access | Times Cited: 2
One-Carbon Metabolism Associated Vulnerabilities in Glioblastoma: A Review
Kimia Ghannad‐Zadeh, Sunit Das
Cancers (2021) Vol. 13, Iss. 12, pp. 3067-3067
Open Access | Times Cited: 15
Metabolomic Profiles of Human Glioma Inform Patient Survival
Andrew J. Scott, Luis O. Correa, Donna M. Edwards, et al.
Antioxidants and Redox Signaling (2023) Vol. 39, Iss. 13-15, pp. 942-956
Open Access | Times Cited: 6
Purine Synthesis Inhibitor L-Alanosine Impairs Mitochondrial Function and Stemness of Brain Tumor Initiating Cells
Simranjit X. Singh, Rui Yang, Kristen Roso, et al.
Biomedicines (2022) Vol. 10, Iss. 4, pp. 751-751
Open Access | Times Cited: 9
Nuclear IMPDH Filaments in Human Gliomas
Narges Ahangari, David G. Muñoz, Josée Coulombe, et al.
Journal of Neuropathology & Experimental Neurology (2021) Vol. 80, Iss. 10, pp. 944-954
Open Access | Times Cited: 12
Clinical Targeting of Altered Metabolism in High-Grade Glioma
Andrew J. Scott, Costas A. Lyssiotis, Daniel Wahl
The Cancer Journal (2021) Vol. 27, Iss. 5, pp. 386-394
Open Access | Times Cited: 12
Growth Transformation of B Cells by Epstein-Barr Virus Requires IMPDH2 Induction and Nucleolar Hypertrophy
Atsuko Sugimoto, Takahiro Watanabe, Kazuhiro Matsuoka, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 4
Open Access | Times Cited: 4
Increasing Ciliary ARL13B Expression Drives Active and Inhibitor-Resistant Smoothened and GLI into Glioma Primary Cilia
Ping Shi, Jia Tian, Julianne C. Mallinger, et al.
Cells (2023) Vol. 12, Iss. 19, pp. 2354-2354
Open Access | Times Cited: 4
Metabolism and signaling crosstalk in glioblastoma progression and therapy resistance
Laura Zarzuela, Raúl V. Durán, Mercedes Tomé
Molecular Oncology (2023)
Open Access | Times Cited: 4
Integrative single-cell and bulk transcriptomes analyses reveals heterogeneity of serine-glycine-one-carbon metabolism with distinct prognoses and therapeutic vulnerabilities in HNSCC
Lixuan Wang, Rongchun Yang, Yue Kong, et al.
International Journal of Oral Science (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 1
IMPDH2 suppression impedes cell proliferation by instigating cell cycle arrest and stimulates apoptosis in pediatric hepatoblastoma
Linman Li, Yichi Wu, Hong-ting Huang, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 8
Open Access | Times Cited: 1
Epigenomic perturbation of novel EGFR enhancers reduces the proliferative and invasive capacity of glioblastoma and increases sensitivity to temozolomide
Craig A. Vincent, Itzel Nissen, Soran Dakhel, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Spatial transcriptomics in glioblastoma: is knowing the right zip code the key to the next therapeutic breakthrough?
Jack Shireman, Lingxin Cheng, Amiti Goel, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3
Multi-Omics Analysis of NCI-60 Cell Line Data Reveals Novel Metabolic Processes Linked with Resistance to Alkylating Anti-Cancer Agents
Blake R. Rushing
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13242-13242
Open Access | Times Cited: 2
Rewiring of cortical glucose metabolism fuels human brain cancer growth
Andrew J. Scott, Anjali Mittal, Baharan Meghdadi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Reuse of Molecules for Glioblastoma Therapy
Abigail Koehler, Aniruddha S. Karve, Pankaj B. Desai, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 2, pp. 99-99
Open Access | Times Cited: 4
Constructing a Nucleotide Metabolism Related Prognostic Model Based on Bioinformatics to Explore the Potential Molecular Mechanisms of Glioblastoma
Luwei Jiang, Zixuan Li, Tao Jiang, et al.
Research Square (Research Square) (2024)
Open Access
Aurora kinase A inhibition plus Tumor Treating Fields suppress glioma cell proliferation in a cilium-independent manner
Jia Tian, Julianne C. Mallinger, Ping Shi, et al.
Translational Oncology (2024) Vol. 45, pp. 101956-101956
Open Access
Oxidative Stress Induced Protein Aggregation via GGCT Produced Pyroglutamic Acid in Drug Resistant Glioblastoma
Deanna Tiek, Xiao Song, Xiaozhou Yu, et al.
(2024)
Closed Access
BMP4 and Temozolomide Synergize in the Majority of Patient-Derived Glioblastoma Cultures
Iris S.C. Verploegh, Andrea Conidi, Hoesna El Hassnaoui, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 10176-10176
Open Access
Brain-penetrating molecule might offer a route to treat glioblastoma tumours
Mushtaq Ahmad Nengroo, Issam Ben‐Sahra
Nature (2024) Vol. 636, Iss. 8042, pp. 307-308
Closed Access
Induction of IMPDH-Based Cytoophidia by a Probable IMP-Dependent ARL13B–IMPDH Interaction
Najva Alijani, Razieh Yazdanparast
Biochemistry (Moscow) (2024) Vol. 89, Iss. 12-13, pp. 2287-2291
Closed Access
Cilia at the Crossroads of Tumor Treating Fields and Chemotherapy
Loic P. Deleyrolle, Matthew R. Sarkisian
Developmental Neuroscience (2023) Vol. 45, Iss. 3, pp. 139-146
Open Access | Times Cited: 1
Ribonucleotide Reductase Regulatory Subunit M2 as a Driver of Glioblastoma TMZ-Resistance through Modulation of dNTP Production
Ella Perrault, Jack Shireman, Eunüs S. Ali, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 2

Scroll to top